Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients

Background: Carfilzomib improves the prognosis of multiple myeloma (MM) patients but significantly increases cardiovascular toxicity. The timing and effect of Carfilzomib therapy on the left ventricular function is still under investigation. We sought to assess the echocardiographic systo-diastolic...

Full description

Bibliographic Details
Main Authors: Giulia Mingrone, Anna Astarita, Lorenzo Airale, Ilaria Maffei, Marco Cesareo, Teresa Crea, Giulia Bruno, Dario Leone, Eleonora Avenatti, Cinzia Catarinella, Marco Salvini, Giusy Cetani, Francesca Gay, Sara Bringhen, Franco Veglio, Fabrizio Vallelonga, Alberto Milan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.645678/full